S1914

S1914: A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT versus SBRT Alone in High Risk, Early Stage NSCLC
Status:

Open

Trial Type:

Contact:

Paul Koffer, MD
pkoffer@brownhealth.org